Skip to main content

Advertisement

Log in

Erhöhte Tumorinzidenz bei ANCA-assoziierten Vaskulitiden

Mögliche Ursachen und Zusammenhänge

ANCA-associated vasculitis and malignancy

Current evidence for cause and consequence relationships

  • Klinische Studien kurzgefasst
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Berden A et al (2012) Diagnosis and management of ANCA associated vasculitis. BMJ 344:e326

    Article  Google Scholar 

  2. Faurschou M et al (2008) Malignancies in Wegener’s granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients. J Rheumatol 35:100–105

    PubMed  CAS  Google Scholar 

  3. Heijl C et al (2011) Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European vasculitis study group clinical trials. Ann Rheum Dis 70:1415–1421

    Article  PubMed  CAS  Google Scholar 

  4. Stone JH et al (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363:221–232

    Article  PubMed  CAS  Google Scholar 

  5. Cartin-Ceba R et al (2012) Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener’s). Arthritis Rheum 64:3770–3778

    Article  PubMed  CAS  Google Scholar 

  6. Vollenhoven RF van (2012) Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients. Ann Rheum Dis (e-pub ahead)

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. M. Zänker ist als Referent für die Firmen Roche, Abbott und MSD tätig und erhielt von diesen Firmen Beraterhonorare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Zänker.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zänker, M. Erhöhte Tumorinzidenz bei ANCA-assoziierten Vaskulitiden. Z. Rheumatol. 72, 921–922 (2013). https://doi.org/10.1007/s00393-013-1283-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-013-1283-x

Navigation